Featured Podcast: Which Studies Are Most Likely to Change the Lives of People With HIV?
Tune in as Joel Gallant, M.D., one of the United States' foremost HIV experts, walks us through some of the most important findings presented at ICAAC/IDSA 2008. This conference included a few studies that may change the landscape of HIV treatment: One study, for instance, strongly suggests that HIVers should start meds well before their CD4 count drops below 350. Other studies highlighted how some of our powerful new HIV meds may become good options for those who are thinking about their first HIV treatment regimen.
E-Mail
Glossary
Share